topiramate sandoz 200 mg filmomh. tabl.
sandoz sa-nv - topiramaat 200 mg - filmomhulde tablet - 200 mg - topiramaat 200 mg - topiramate
topiramate sandoz 25 mg filmomh. tabl.
sandoz sa-nv - topiramaat 25 mg - filmomhulde tablet - 25 mg - topiramaat 25 mg - topiramate
topiramate sandoz 50 mg filmomh. tabl.
sandoz sa-nv - topiramaat 50 mg - filmomhulde tablet - 50 mg - topiramaat 50 mg - topiramate
lacosamide adroiq
extrovis eu ltd. - lacosamide - epilepsie - van anti-epileptica, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.
rivotril 0,5 mg tabl.
cheplapharm arzneimittel gmbh - clonazepam 0,5 mg - tablet - 0,5 mg - clonazepam 0.5 mg - clonazepam
trileptal 150 mg filmomh. tabl.
novartis pharma sa-nv - oxcarbazepine 150 mg - filmomhulde tablet - 150 mg - oxcarbazepine 150 mg - oxcarbazepine
trileptal 300 mg filmomh. tabl.
novartis pharma sa-nv - oxcarbazepine 300 mg - filmomhulde tablet - 300 mg - oxcarbazepine 300 mg - oxcarbazepine
trileptal 600 mg filmomh. tabl.
novartis pharma sa-nv - oxcarbazepine 600 mg - filmomhulde tablet - 600 mg - oxcarbazepine 600 mg - oxcarbazepine
diacomit
biocodex - stiripentol - myoclonic epilepsy, juvenile - van anti-epileptica, - diacomit is geïndiceerd voor gebruik in combinatie met clobazam en valproate als adjuvante therapie van vuurvaste gegeneraliseerde tonic-klonische aanvallen bij patiënten met ernstige myoclonische epilepsie in kinderschoenen (smei, het dravet syndroom) waarvan vangsten niet voldoende zijn gecontroleerd met clobazam en valproate.
lacosamide accord
accord healthcare s.l.u. - lacosamide - epilepsie - van anti-epileptica, - lacosamide accord is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. lacosamide accord is indicated as adjunctive therapy• in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. • in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.